Kempen Capital Management N.V. Novo Nordisk A S Transaction History

Kempen Capital Management N.V.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$63.89 - $73.8 $38,397 - $44,353	-601 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$58.54 - $67.94 $116,260 - $134,928	-1,986 Reduced 76.77%	601 $39,000
Q1 2020 May 15, 2020	BUY	$49.46 - $64.78 $28,390 - $37,183	574 Added 28.51%	2,587 $156,000
Q4 2019 Feb 14, 2020	SELL	$49.86 - $58.26 $574,885 - $671,737	-11,530 Reduced 85.14%	2,013 $117,000
Q3 2019 Nov 14, 2019	BUY	$47.54 - $53.43 $643,834 - $723,602	13,543 New	13,543 $700,000

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $198B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Kempen Capital Management N.V., based on Form 13F filings with the SEC.

Stay updated on Kempen Capital Management N.V. with notifications on news.